Is Mediwound Stock a Good Investment?

Mediwound Investment Advice

MDWD

To provide specific investment advice or recommendations on Mediwound stock, we recommend investors consider the following general factors when evaluating Mediwound. This will help you to make an informed decision on whether to include Mediwound in one of your diversified portfolios:

Examine Mediwound's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
Research Mediwound's leadership team and their track record. Good management can help Mediwound navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
Consider the overall health of the Pharmaceutical Products space and any emerging trends that could impact Mediwound's business and its evolving consumer preferences.
Compare Mediwound's performance and market position to its competitors. Analyze how Mediwound is positioned in terms of product offerings, innovation, and market share.
Check if Mediwound pays a dividend and its dividend yield and payout ratio.
Review what financial analysts are saying about Mediwound's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.

It's important to note that investing in Mediwound stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Mediwound is a good investment.

Sell

Buy

Sell

Our investment recommendation tool can cross-verify current analyst consensus on Mediwound and to analyze the entity potential to grow in the current economic cycle. To make sure Mediwound is not overpriced, please verify all Mediwound fundamentals, including its ebitda, cash flow from operations, and the relationship between the price to book and total debt . Given that Mediwound has a price to earning of 16.58 X, we recommend you to check Mediwound market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your last-minute risk tolerance and investing horizon.

Market Performance	Modest	Details
Volatility	Not too volatile	Details
Hype Condition	Stale	Details
Current Valuation	Overvalued	Details
Odds Of Distress	Low	Details
Economic Sensitivity	Barely shadows the market	Details
Investor Sentiment	Alarmed	Details
Analyst Consensus	Not Available	Details
Financial Leverage	Not Rated	Details
Reporting Quality (M-Score)	Unavailable	Details

Examine Mediwound Stock

Researching Mediwound's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 20.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 2.91. Mediwound had not issued any dividends in recent years. The entity had 1:7 split on the 20th of December 2022.

To determine if Mediwound is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Mediwound's research are outlined below:

	Mediwound had very high historical volatility over the last 90 days
	The company reported the previous year's revenue of 18.69 M. Net Loss for the year was (6.72 M) with profit before overhead, payroll, taxes, and interest of 2.45 M.
	Mediwound currently holds about 10.41 M in cash with (10.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.31.
	Roughly 20.0% of the company outstanding shares are owned by corporate insiders

Mediwound uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Mediwound. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Mediwound's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.

	21st of March 2024 Upcoming Quarterly Report	View
	4th of June 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	21st of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

Mediwound's market capitalization trends

The company currently falls under 'Small-Cap' category with a current market capitalization of 207.92 M.

Mediwound's profitablity analysis

The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.17) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.17.

Determining Mediwound's profitability involves analyzing its financial statements and using various financial metrics to determine if Mediwound is a good buy. For example, gross profit margin measures Mediwound's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Mediwound's profitability and make more informed investment decisions.

Please note, the presentation of Mediwound's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mediwound's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Mediwound's management manipulating its earnings.

Basic technical analysis of Mediwound Stock

As of the 20th of March, Mediwound secures the Risk Adjusted Performance of 0.0656, mean deviation of 2.82, and Downside Deviation of 3.6. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mediwound, as well as the relationship between them. Please verify Mediwound treynor ratio, and the relationship between the standard deviation and downside variance to decide if Mediwound is priced some-what accurately, providing market reflects its recent price of 18.28 per share. Given that Mediwound has jensen alpha of 0.2323, we recommend you to check Mediwound's last-minute market performance to make sure the company can sustain itself at a future point.

Mediwound's Outstanding Corporate Bonds

Mediwound issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Mediwound uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Mediwound bonds can be classified according to their maturity, which is the date when Mediwound has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

	MPLX LP 4875 Corp Bond US55336VAJ98	View
	MPLX LP 52 Corp Bond US55336VAL45	View
	Morgan Stanley 3591 Corp Bond US61744YAK47	View
	Morgan Stanley 3971 Corp Bond US61744YAL20	View
	Valero Energy Partners Corp Bond US91914JAA07	View

View All Mediwound Corporate Bonds

Understand Mediwound's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Mediwound's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

	Risk Adjusted Performance	0.0656
	Market Risk Adjusted Performance	2.49
	Mean Deviation	2.82
	Semi Deviation	3.43
	Downside Deviation	3.6
	Coefficient Of Variation	1528.5
	Standard Deviation	3.6
	Variance	12.96
	Information Ratio	0.0834
	Jensen Alpha	0.2323
	Total Risk Alpha	0.5294
	Sortino Ratio	0.0835
	Treynor Ratio	2.48
	Maximum Drawdown	16.67
	Value At Risk	(5.81)
	Potential Upside	4.44
	Downside Variance	12.93
	Semi Variance	11.8
	Expected Short fall	(3.05)
	Skewness	0.0437
	Kurtosis	0.1121

	Risk Adjusted Performance	0.0656
	Market Risk Adjusted Performance	2.49
	Mean Deviation	2.82
	Semi Deviation	3.43
	Downside Deviation	3.6
	Coefficient Of Variation	1528.5
	Standard Deviation	3.6
	Variance	12.96
	Information Ratio	0.0834
	Jensen Alpha	0.2323
	Total Risk Alpha	0.5294
	Sortino Ratio	0.0835
	Treynor Ratio	2.48
	Maximum Drawdown	16.67
	Value At Risk	(5.81)
	Potential Upside	4.44
	Downside Variance	12.93
	Semi Variance	11.8
	Expected Short fall	(3.05)
	Skewness	0.0437
	Kurtosis	0.1121

Consider Mediwound's intraday indicators

Mediwound intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Mediwound stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

	Accumulation Distribution	0.0737
	Daily Balance Of Power	(0.68)
	Rate Of Daily Change	0.95
	Day Median Price	18.95
	Day Typical Price	18.73
	Market Facilitation Index	1.45
	Price Action Indicator	(1.17)
	Period Momentum Indicator	(0.99)
	Relative Strength Index	52.27

Mediwound time-series forecasting models is one of many Mediwound's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Mediwound's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Mediwound Stock media impact

Far too much social signal, news, headlines, and media speculation about Mediwound that are available to investors today. That information is available publicly through Mediwound media outlets and privately through word of mouth or via Mediwound internal channels. However, regardless of the origin, that massive amount of Mediwound data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.

A primary focus of Mediwound news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mediwound relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mediwound's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mediwound alpha.

Mediwound Corporate Management

Yaron Adv	General VP	Profile
CPA CPA	Ex Director	Profile
Ofer BSc	Chief Officer	Profile
Hani Luxenburg	Chief Officer	Profile
CWS DPM	Chief Officer	Profile

When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports: